Institute of Tropical Medicine, Belgium: Malaria trials

The registry lists 18 Malaria studies with Institute of Tropical Medicine, Belgium as lead sponsor. 1 are open to participants now and 1 have results posted.

Phase 2 1Phase 3 7Phase 4 2No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Clinical Aspects, Management and Surveillance of Febrile Illnesses in DRCRecruitingNCT07345286
• Malaria as a Protection Factor Against Severe COVID-19 (Known as SARS-COV-2) in the Democratic Republic of Congo (Palu-COVID)TerminatedNCT05012280Results posted
• Host Immune and Metabolic Determinants of Sexual Conversion in Plasmodium Parasites IMMETASEXCompletedNCT06064591
• Clinical Decision Support in Non-typhoidal Salmonella Bloodstream Infections in ChildrenCompletedNCT04473768
• Health Itinerary of Young Children With Suspected Bloodstream Infection in Kisantu General Referral Hospital, DR CongoCompletedNCT04289688
• Use of Malaria Rapid Diagnostic Tests as a Decision Aid for the Management of Fever by International TravelersWithdrawnNCT02900079
• Repellents as Added Control Measure to Long Lasting Insecticidal NetsCompletedNCT01663831Not applicable
• Establishing Effectiveness of Daily Co-trimoxazole Prophylaxis For Prevention of Malaria in PregnancyCompletedNCT01053325Phase 3
• A Cluster Randomized Trial to Evaluate Long Lasting Insecticidal Hammocks to Prevent Forest Malaria in VietnamCompletedNCT00853281Not applicable
• Safe and Efficacious Artemisinin-based Combination Treatments for African Pregnant Women With MalariaCompletedNCT00852423Phase 3
• New Approaches to Improve Coverage and Compliance of Antimalarial Treatment for Pregnant Women in Rural AfricaCompletedNCT00730366Phase 3
• Daily Co-trimoxazole Prophylaxis to Prevent Malaria in PregnancyTerminatedNCT00711906Phase 3
• Pharmacokinetic of Mefloquine-Artesunate in Plasmodium Falciparum Malaria Infection in PregnancyCompletedNCT00701961Phase 2/3
• Prevention of Intrauterine Growth Retardation in Burkina Faso: the Malaria ComponentCompletedNCT00680732Phase 4
• Evaluation of 4 Artemisinin-based Combinations for Treating Uncomplicated Malaria in African ChildrenCompletedNCT00393679Phase 3
• Efficacy and Safety of Dihydroartemisinin/Piperaquine (Artekin®) for the Treatment of Uncomplicated Malaria in PeruCompletedNCT00373607Phase 3
• IPT of Malaria With SP in Different Zones of Drug Resistance in RwandaCompletedNCT00372632Phase 4
• Comparative Evaluation of the Safety and the Efficacy of 2 Antimalarials Depending on HIV StatusTerminatedNCT00304980Not applicable